Lam Research Corp
(LRCX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,396,352 | 2,374,574 | 1,179,744 | 3,908,458 | 2,763,801 |
| Depreciation Amortization | 245,807 | 161,579 | 79,874 | 307,151 | 228,754 |
| Income taxes - deferred | -83,451 | -26,573 | -13,023 | -151,477 | -5,448 |
| Accounts receivable | N/A | N/A | N/A | -928,928 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 184,615 | N/A |
| Other Working Capital | -1,014,119 | -657,279 | -838,480 | -678,741 | -1,009,116 |
| Other Operating Activity | 111,151 | 45,729 | 49,409 | 947,085 | 174,237 |
| Operating Cash Flow | $2,655,740 | $1,898,030 | $457,524 | $3,588,163 | $2,152,228 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,142,398 | 1,063,214 | 738,043 | 464,522 | -335,443 |
| PPE Investments | -420,288 | -274,920 | -136,427 | -349,096 | -244,474 |
| Other Investing Activity | -33,898 | -5,518 | -4,923 | -42,155 | -35,873 |
| Investing Cash Flow | $688,212 | $782,776 | $596,693 | $73,271 | $-615,790 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -9,857 | -8,036 | -6,338 | -862,060 | -40,014 |
| Common Stock Issued | 51,065 | 50,573 | 742 | 121,887 | 64,706 |
| Common Stock Repurchased | -2,989,574 | -1,651,568 | -1,236,753 | -2,697,704 | -2,266,449 |
| Dividend Paid | -607,234 | -396,647 | -185,431 | -726,992 | -541,607 |
| Other Financing Activity | 197 | -17 | 188 | -2,113 | -1,844 |
| Financing Cash Flow | $-3,555,403 | $-2,005,695 | $-1,427,592 | $-4,166,982 | $-2,785,208 |
| Exchange Rate Effect | -13,544 | -8,454 | -3,776 | 7,215 | 6,513 |
| Beginning Cash Position | 4,670,750 | 4,670,750 | 4,670,750 | 5,169,083 | 5,169,083 |
| End Cash Position | 4,445,755 | 5,337,407 | 4,293,599 | 4,670,750 | 3,926,826 |
| Net Cash Flow | $-224,995 | $666,657 | $-377,151 | $-498,333 | $-1,242,257 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,655,740 | 1,898,030 | 457,524 | 3,588,163 | 2,152,228 |
| Capital Expenditure | -420,288 | -274,920 | -136,427 | -349,096 | -244,474 |
| Free Cash Flow | 2,235,452 | 1,623,110 | 321,097 | 3,239,067 | 1,907,754 |